EDGAR Filing Documents for 0001193125-21-055823

Form 8-K - Current report:

SEC Accession No. 0001193125-21-055823

Filing Date

2021-02-25

Accepted

2021-02-25 08:19:29

Documents

Period of Report

2021-02-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d61211d8k.htm	8-K	42856
2	EX-2.1	d61211dex21.htm	EX-2.1	535031
3	EX-99.1	d61211dex991.htm	EX-99.1	91007
4	EX-99.2	d61211dex992.htm	EX-99.2	28801
5	GRAPHIC	g61211122.jpg	GRAPHIC	3534
6	GRAPHIC	g61211dsp01.jpg	GRAPHIC	4572
	Complete submission text file	0001193125-21-055823.txt		710578

Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472

Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925

Pandion Therapeutics, Inc. (Filer) CIK: 0001807901 (see all company filings)